Hero image with Pittsburgh background https://pittplusme.org/study/941

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Do you have heart disease? Have you either been hospitalized for heart failure in the past 2 years, or have you had a heart attack in the past year? If so, you may be able to participate in a research study to help find out if a high-dose flu vaccine can reduce the rate of death or hospitalization from heart- or lung-related causes. Vaccination provided at no cost to participants.


STUDY PURPOSE
People with heart disease who get the flu (influenza) have a higher risk of being hospitalized or dying due to flu-related complications. Getting a yearly flu shot can reduce this risk. The flu vaccine is available in different formulations. Most people receive the standard-dose vaccine. A high-dose vaccine is also FDA-approved for use in adults 65 years of age or older, but it is considered investigational when used with younger adults. Some research suggests that receiving a high-dose vaccine can decrease the likelihood of getting the flu for people with heart disease. The purpose of this study is to help researchers find out if the high-dose flu vaccine is more effective than the standard-dose flu vaccine at reducing the rate of hospitalization or death in people with heart disease.
COULD THIS STUDY BE RIGHT FOR YOU?
  • Age 18 and up
  • Hospitalized for a heart attack in the past year, or hospitalized for heart failure in the past 2 years
  • Have at least one heart disease risk factor, such as obesity, smoking, high blood pressure, diabetes, or high cholesterol
  • Have NOT received a flu shot this season

WHAT PARTICIPANTS CAN EXPECT
Participation involves 3 visits lasting about 90 minutes-2 hours. Researchers will collect your medical record information and randomly (like the flip of a coin) assign you to receive either the high-dose flu shot (which is investigational in adults under 65), or the standard-dose flu shot. After receiving the shot (which may be done on a different day if desired) participants must stay in the clinic for 20 minutes so the study team can watch for any vaccine-related reactions. Participants will also be asked to record any side effects they experience from the vaccination for 7 days, and will receive 3 follow-up phone calls from the study team. You may also choose to continue in the study and receive a study flu shot in years 2 and 3. Follow-up reporting and calls will be the same as in year 1. The flu shot is provided to participants at no cost.
IRB: 2016-0640-CP002
- INfluenza Vaccine to Effectively Stop CardioThoracic Events and Decompensated heart failure (INVESTED)

RESEARCH AREAS:
  Heart and Circulation

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/941 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Kathleen McTigue

Kathleen M. McTigue, MD, MPH is an associate professor at the University of Pittsburgh's Department of Medicine. Her main area of research interest is the prevention of chronic disease and the promotion of healthy behaviors.